Literature DB >> 33380165

Course and Recognition of Poststroke Delirium: A Prospective Noninferiority Trial of Delirium Screening Tools.

Robert Fleischmann1, Sina Warwas1, Tina Andrasch1, Rhina Kunz1, Carl Witt1, Annerose Mengel2, Bettina von Sarnowski1.   

Abstract

BACKGROUND AND
PURPOSE: Poststroke delirium (PSD) is an independent predictor of unfavorable outcome. Despite its individual and socioeconomic burden, its frequency, clinical course, and routine detection remain unresolved. This study aimed to assess psychometric properties of established delirium screening tools and investigate the natural course of PSD.
METHODS: This study investigated patients presenting with high-risk transient ischemic attacks or ischemic stroke within 24 hours during a 3-month period. Twice-daily screenings for PSD were done using the confusion assessment method, nursing delirium scale, and rapid delirium assessment, and evaluated for noninferiority against Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria. We investigated demographic and stroke characteristics as predictors of PSD, neurological deficits as predictors of false screening results, and conducted a simulation study to estimate the best timing to identify PSD.
RESULTS: We enrolled 141 patients (73.8±10.4 years of age, 61 female) with a mean National Institutes of Health Stroke Scale score of 6.4±6.5. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition based PSD incidence was 39%, which manifested within 24 hours in 25% and 72 hours in almost all cases. The confusion assessment method was the only screening tool noninferior to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition ratings providing a sensitivity of 82% and specificity of 80%. Age (odds ratio, 1.07 [1.02-1.13] per year, P=0.004) and National Institutes of Health Stroke Scale (odds ratio, 1.24 [1.15-1.34] per point, P<0.001) were predictors of PSD. False-positive screening results were associated with stroke-induced disorientation (odds ratio, 6.1 [3.2-11.61], P<0.001) and neglect (odds ratio, 2.17 [1.22-3.87], P=0.008). Simulations revealed that one in 4 cases is missed with less than daily screenings.
CONCLUSIONS: PSD is a common complication of stroke and transient ischemic attack. Detection is challenged by confounding effects such as focal neurological deficits and the necessity for at least daily screenings. Future studies are required to investigate implementation of these findings in clinical routine. Registration: URL: https://www.clinicaltrials.gov. Unique identifier: NCT03930719.

Entities:  

Keywords:  delirium; incidence; risk factors; screening; sensitivity and specificity; stroke

Mesh:

Year:  2020        PMID: 33380165     DOI: 10.1161/STROKEAHA.120.031019

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

1.  Impact of delirium on the outcome of stroke: a prospective, observational, cohort study.

Authors:  Eleonora Rollo; Valerio Brunetti; Irene Scala; Antonio Callea; Jessica Marotta; Catello Vollono; Giovanni Frisullo; Aldobrando Broccolini; Paolo Calabresi; Giacomo Della Marca
Journal:  J Neurol       Date:  2022-08-09       Impact factor: 6.682

2.  The relationship of acute delirium with cognitive and psychiatric symptoms after stroke: a longitudinal study.

Authors:  Vilde Nerdal; Elise Gjestad; Ingvild Saltvedt; Ragnhild Munthe-Kaas; Hege Ihle-Hansen; Truls Ryum; Stian Lydersen; Ramune Grambaite
Journal:  BMC Neurol       Date:  2022-06-27       Impact factor: 2.903

3.  Heart rate variability and delirium in acute non-cardioembolic stroke: a prospective, cross-sectional, cohort study.

Authors:  Eleonora Rollo; Jessica Marotta; Antonio Callea; Valerio Brunetti; Catello Vollono; Irene Scala; Claudio Imperatori; Giovanni Frisullo; Aldobrando Broccolini; Giacomo Della Marca
Journal:  Neurol Sci       Date:  2021-09-29       Impact factor: 3.830

Review 4.  The Role of Vascular Risk Factors in Post-Stroke Delirium: A Systematic Review and Meta-Analysis.

Authors:  Vasileios Siokas; Robert Fleischmann; Katharina Feil; Ioannis Liampas; Markus C Kowarik; Yang Bai; Maria-Ioanna Stefanou; Sven Poli; Ulf Ziemann; Efthimios Dardiotis; Annerose Mengel
Journal:  J Clin Med       Date:  2022-10-01       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.